Background: Although commonly used, early initiation of salvage androgen deprivation therapy (ADT) has not been proven to enhance survival. We evaluated whether prostate-specific antigen (PSA) anxiety or health literacy are associated with use of early salvage ADT among men with recurrent prostate cancer after radiotherapy.
introduction
Prostate cancer is the most common non-cutaneous malignancy in men, with a projected 238 590 new cases of prostate cancer and 29 480 deaths due to prostate cancer in the United States in 2014 [1] . Radical prostatectomy or radiation therapy is potentially curative treatments for localized disease [2, 3] . Still more than one in four patients will recur after localized therapy within 10 years [4, 5] .
Prostate-specific antigen (PSA) monitoring allows for identification of men with asymptomatic biochemical recurrence. Although androgen deprivation therapy (ADT) is part of the standard initial management approach to men with metastatic prostate cancer, no survival benefit has been reported among men with PSA-only recurrence after radiotherapy (who may not develop overtly metastatic disease for years) who receive early salvage ADT, and ADT is costly and is associated with several known clinical side-effects [6] [7] [8] . Furthermore, the estimated direct annual cost from unproven ADT use is $42 000 and adverse events increase the costs of ADT by 100%-265% [9, 10] .
Although immediate ADT provides a modest survival benefit among patients with prostate cancer not suitable for local treatment [11] , recently presented evidence from the CaPSURE database suggests that there is little or no survival benefit from immediate ADT initiation compared with deferred ADT initiation (at clinical progression or 2 years after PSA relapse) among patients with biochemical recurrence after localized therapy [12] . Two ongoing randomized clinical trials, a Canadian trial (NCT00439751) and an Australian trial (NCT00110162), aim to further evaluate the role of early salvage ADT. Given that there is no consensus regarding the optimal timing of ADT initiation in patients with biochemical recurrence and the concerning clinical and economic consequences of unproven use of ADT, it is critical to understand patient-level factors as potential drivers of early salvage ADT to better inform health care policy and quality improvement strategies.
In this study, we used the prospective Comprehensive, Observational, Multicenter, Prostate Adenocarcinoma Registry (COMPARE) to determine whether PSA anxiety or health literacy are associated with unproven use of early salvage ADT as initial management for PSA recurrence following radiotherapy.
methods patient selection
The prospective COMPARE registry was opened across 150 geographically diverse sites throughout the United States in February 2004 and enrolled 1120 men with biochemical recurrence after primary therapy for localized prostate cancer through March 2007 [13] . Men of any age presenting with an increasing PSA after treatment of primary nonmetastatic prostate adenocarcinoma with either radical prostatectomy or radiation therapy [external beam radiation therapy (EBRT) or brachytherapy] were eligible for this observational, prospective database, with PSA inclusion criteria as follows: (i) an increase of ≥0.2 ng/ml on repeated testing after radical prostatectomy or (ii) two increases greater than the nadir, with a PSA value ≥50% greater than the nadir and a minimal PSA value ≥0.2 ng/ml greater than the postradiation therapy nadir (a steering committee recommended modification of the Phoenix definition). Patients who received adjuvant or neoadjuvant ADT for ≤3 years were eligible but must have ceased ADT for >4 months before enrollment. Exclusion criteria included any ongoing treatment of prostate cancer and certain comorbidities. The full exclusion criteria have been detailed in previous reports and are provided in supplementary Figure 1 , available at Annals of Oncology online [13] .
To be included in the current study, patients must have received radiotherapy (EBRT or brachytherapy) but not radical prostatectomy as initial treatment. Furthermore, patients must have had complete information on demographic characteristics of interest including PSA anxiety and health literacy; N = 110 patients were excluded for missing data (supplementary Figure 1 , available at Annals of Oncology online). A total of 375 patients met these inclusion criteria and constituted the study cohort.
data collection
On enrollment into the study, data obtained from each patient included prostate cancer history, comorbidities, current physical examination parameters and pertinent laboratory data, and patient-reported common complaints. Each patient also completed a questionnaire including questions on demographics, medical problems, anxiety about PSA, and the impact on quality of life during the previous 4 weeks. Patients gave informed consent and the data were made anonymous. Each participating site submitted registry documents to the central or local Institutional Review Board and obtained written approval before conduction any registry-related procedures.
Investigators obtained informed consent from patients and provided them with a Health Insurance Portability and Accountability Act statement before enrollment.
definition of PSA anxiety and health literacy PSA anxiety at study enrollment was assessed using three questions from the baseline questionnaire, which are validated questions originally developed as a part of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) index [14] . If a patient responded 'sometimes' or 'often' to any one of the following (three) statements: (i) 'I have been so anxious about my PSA test that I have thought about delaying it,' (ii) 'I have been so worried about my PSA test result that I have thought about asking my doctor to repeat it,' or (iii) I have been so concerned about my PSA test result that I have thought about having the test repeated at another laboratory to make sure it was accurate,' then he was considered to have PSA anxiety. If a patient responded 'not at all' or 'rarely' to all (three) statements, then he was not considered to have PSA anxiety.
Health literacy was determined based on the Rapid Estimation of Literacy of Medicine (REALM-SF), a reliable and validated short form derived from the widely used and validated longer (66-word) REALM form [15] . English-speaking persons were asked to pronounce the following seven words aloud: 'Menopause, Exercise, Rectal, Behavior, Antibiotics, Jaundice, and Anemia.' We collapsed health literacy findings into two mutually exclusive groups: ninth grade or higher health literacy (all 7 words pronounced correctly) or less than ninth grade health literacy (<7 words pronounced correctly).
statistical analysis
Baseline clinical and demographic characteristics by receipt of salvage ADT were characterized and compared using Fisher's exact test. Univariable and multivariable logistic regression was used to determine whether PSA anxiety and health literacy were associated with salvage ADT as initial management for PSA recurrence following radiation therapy. In addition to PSA anxiety and health literacy, multivariable analyses were adjusted for age, time from primary therapy, race, living situation (lives with partner versus not), education (graduated high school versus not), cardiovascular comorbidities, PSA at study enrollment (PSA closest to recurrence), PSA doubling time (PSADT), Gleason score, and T stage. Adjusted odds ratios (AORs) and 95% confidence interval (CIs) were reported for each covariate and a P value of <0.05 was used to determine statistical significance. SAS version 9.3 (SAS Institute, Cary, NC) was used for all calculations.
results

patient baseline characteristics
Baseline patient clinical and demographic characteristics by receipt of salvage ADT as initial management after biochemical recurrence are displayed in Table 1 . The median time from prior local therapy to the administration of the questionnaires for the entire cohort was 5.1 years [interquartile range (IQR): 2.9 to 7.9 years). The study cohort included a total of 375 men who received radiotherapy as initial treatment of primary nonmetastatic prostate adenocarcinoma and for whom complete information was available on PSA anxiety, health literacy, race, educational status, age, living situation, comorbidity, PSA at recurrence/study entry, PSADT, Gleason score, and T stage. PSA, Gleason score, and clinical T stage did not differ by receipt of salvage ADT (all P > 0.05). However, patients who received salvage ADT after biochemical 14; P = 0.007) remained significantly associated with receipt of salvage ADT (Table 2) . Having health literacy levels greater than ninth grade trended toward being significantly associated with receipt of salvage ADT (AOR 0.58; 95% CI 0.32-1.05; P = 0.07).
discussion
Using a large multicenter, prospective registry, we found that 18.1% of men with biochemically recurrent prostate cancer after radiotherapy received salvage ADT as initial management. Regression analyses identified two patient-level factors associated with about twofold increased odds of receiving salvage ADT following PSA recurrence among men who received initial radiotherapy-higher levels of PSA anxiety and lower than ninth grade health literacy levels. On multivariable analysis, PSA anxiety remained significant and health literacy was near-significant (P = 0.07). Furthermore, patients with PSADT <12 months were more than twice as likely to receive salvage ADT when compared with those with PSADT ≥12 months; PSADT <12 months was the only disease-specific characteristic associated with initiation of salvage ADT on multivariable analysis.
These results emphasize novel patient-level factors, namely anxiety about PSA level or low health literacy, which were associated with a significantly higher rate of receipt of salvage ADT after biochemically recurrent prostate cancer. These patient factors had a stronger association with receipt of salvage ADT compared with PSA level at recurrence, Gleason score, and clinical T stage. Furthermore, patients with PSA anxiety were more likely to have a shorter time from initial therapy indicating that time from initial treatment may have been a driver of PSA anxiety and in turn receipt of salvage ADT. Still, PSA anxiety remained strongly associated with receipt of salvage ADT even after adjusting for time from primary treatment. These findings suggest that patient-level concern or understanding are significant drivers, potentially equal in magnitude to the effect of PSADT, of receipt of salvage ADT at biochemical recurrence after radiotherapy and men with high PSA anxiety or low health literacy may be more likely to push for or accept treatment without a proven survival benefit despite potentially harmful toxicities and side-effects. These are particularly important findings since there are no randomized trials which examine the efficacy of salvage ADT in the PSA-only recurrence setting and it remains unknown the degree to which psychological and demographic factors contribute to treatment decisions at biochemical recurrence. Cancer anxiety and health literacy, therefore, represent targetable patient factors that should inform quality improvement strategies aimed at reducing the costs and toxicities associated with unproven use of ADT. Patient knowledge, attitudes, and beliefs are associated with variations in prostate cancer care. In particular, men with prostate cancer and high anxiety about their cancer who are being monitored with active surveillance have shorter times to initiation of prostate cancer treatment [16] . It may be the case that patient cancer-specific anxiety is communicated as a preference to initiate treatment and treating providers are likely to take patient preference into account when making management decisions [17, 18] . Thus, cancer-specific anxiety may lead to higher rates of salvage ADT among men with biochemically recurrent prostate cancer. A prior study focusing on a small cohort of men with biochemically recurrent prostate cancer (n = 67) similarly demonstrated that cancer anxiety was the most robust factor that lead to early initiation of salvage ADT [19] . Interestingly, in the aforementioned study, Dale et al. found that physicians reported that they took patient preference into high consideration when making treatment decisions, but did not believe patient anxiety was an important factor in initiation of salvage ADT [20] . The fact that cancer anxiety was still the strongest predictor of salvage ADT indicates that patient anxiety is likely linked to patient treatment preferences and physicians should attempt to uncover, address, and alleviate patient anxiety in order to reveal patient treatment preferences that are not influenced by underlying anxiety about disease. Furthermore, prior studies report that higher levels of education are associated with more aggressive prostate cancer treatment [21, 22] . However, health literacy differs markedly from educational status-many persons achieve high educational levels, while health literacy skills are poor-as reported in prior studies of education and health literacy in cancer screening initiatives [20, 23, 24] . Among men with prostate cancer, those with low health literacy are more likely to choose inappropriate treatment regimens when they participate in shared decision-making programs in comparison to men with higher literacy [25] . Our findings extend our prior work on patient treatment choice following shared decision-making initiatives for men with prostate cancer treatment who are faced with different options [26] . Conversely, our findings differ from previous studies of health literacy and use of cancer screening tests-in those studies, patients with low health literacy skills were less likely to undergo routine cancer screening [27, 28] .
Although further studies are necessary to determine what drives higher rates of salvage treatment in the PSA-only recurrence setting among men with high cancer-specific anxiety or low health literacy, these two factors represent immediately targetable patient features that providers should address. Specifically, given that early salvage ADT can cause significant side-effects and does not necessarily improve survival, oncologists should ensure that anxious and less health literate patients are adequately counseled about the benefits and risks of salvage ADT before they decide to pursue therapy. A concerted effort to ensure that patients' worries, anxieties, and uncertainties are addressed could prevent many patients from undergoing early initiation of salvage ADT.
With respect to persons with low health literacy, our findings also provide empirical support for future interventions that might improve care of these men. There have been a long series of targeted interventions conducted by research assistants, nurses, or physicians that are cost-effective and yet result in marked improvements in cancer screening care [26, [29] [30] [31] . Some of these interventions include: enhanced care (where research assistants help arrange close follow-up to conveniently located providers and encourage patients to discuss screening and treatment options with their providers), informed education (where research assistants provide brief education about the patient's disease using plain language and teach back methods and the patients are also provided with educational videos and pamphlets at the 5th grade level), or nursing support (where a nurse provides educational support, brief counseling, recommendations, and encourages patients to discuss their disease with their providers) [31] . These low-intensity interventions are either conducted at the point-of-care or via telephone and have markedly increased screening rates among persons with poor health literacy levels. While they are readily adapted to the cancer treatment setting, formal evaluations of efficacy, downsides (off-target effects), costs, and cost-effectiveness are needed to fully inform the initiative.
Our results must be viewed within the limitations of the study. First, although we were able to demonstrate that PSA anxiety and health literacy were significantly associated with receipt of salvage treatment, we were not able to determine whether these factors actually had any influence on treating provider decisions since providers did not complete questionnaires as part of the COMPARE study. Second, we did not have information on and were unable to adjust for baseline anxiety disorders or anxiolytic use, both of which could have accentuated PSA anxiety. Third, we did not have information on physician behaviors, anxiety, or preferences, any of which could have exacerbated patient PSA anxiety and decision to receive salvage ADT. Fourth, we did not have information on length of salvage ADT treatment or use of intermittent therapy. Lastly, we were not able to determine whether patients actually preferred salvage treatment or not and we therefore were unable to make conclusions about treatment preferences based on anxiety or health literacy.
Despite these potential limitations, our study contributes novel and compelling information about understudied patientlevel psychological and demographic factors that are associated with receipt of salvage ADT in the biochemically recurrent setting. Namely, we found that PSA anxiety or low health literacy were the most robust predictors of receipt of salvage ADT. A concerted effort should be made to ensure that anxious patients are adequately counseled about the benefits and risks of salvage ADT before they decide to pursue therapy. In contrast, among men with poor health literacy skills, shared decision programs and counseling have been less effective previously and consideration should be for extending previously successful low-literacy targeted interventions from the cancer screening setting to the setting of PSA failure following radiotherapy and decisions to use or not use ADT.
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